Sanofi India Ltd - 500674 - Results- Financials Results For September 30 2023
Results- Financials Results for September 30 202308-11-2023
08-11-2023
Sanofi India Ltd - 500674 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2023
Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we enclose a copy of Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 30th September 2023 approved at the board meeting along with a copy of Limited Review Report.08-11-2023
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (listing Obligations and Disclosures Requirements), Regulations 2015 we would like to inform you that the company has approved to issue of duplicate share certificate requests in lieu of the original share certificate reported/loss misplaced.07-11-2023
Sanofi India Ltd - 500674 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Outcome of Postal ballot06-11-2023
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold an investor / analysts call on Financial Results of Q3 for the Financial Year 2023 on 15th November 2023 at 2:00 p.m.06-11-2023
Sanofi India's Goa plant: Women gain approval to work night shifts!
In a groundbreaking move, Sanofi India's Goa pharmaceutical plant will allow women to work the night shift starting in December, becoming the first in Goa to gain government approval for all shifts, including the 7 p.m. to 6 a.m. slot.04-11-2023
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release made by Sanofi a promoter of Sanofi India Limited.27-10-2023
Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the company has approved issue of Duplicate share certificates request in lieu of the original share certificates reported lost/misplaced.23-10-2023
Sanofi India Ltd - 500674 - Board Meeting Intimation for Board Meeting Intimation For Consideration Of Unaudited Financial Results For The Quarter And Nine Months Ended 30TH September 2023.
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Wednesday, 8th November 2023; inter-alia to consider the Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended 30th September 2023.19-10-2023
Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management17-10-2023